Inventor

CARSON DENNIS A

US74 patents

⚠️ This page may combine multiple inventors who share the name “CARSON DENNIS A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CARSON DENNIS A

UNIV CALIFORNIA

Immunostimulatory polynucleotide/immunomodulatory molecule conjugates

Immunostimulatory polynucleotide/immunomodulatory molecule conjugates

Method for treating allergic lung disease

Method for treating allergic lung disease

Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides

Method for treating allergic lung disease

Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory

Conjugates of synthetic TLR agonists and uses therefor

Compounds for inhibition of ceramide-mediated signal transduction

Devices for administration of naked polynucleotides which encode biologically active peptides

Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides

Compounds for inhibition of ceramide-mediated signal transduction

Method for early diagnosis of, and determination of prognosis in, cancer

Use of etodolac for the treatment of chronic lymphocytic leukemia

Polymerase chain reaction assays to determine the presence and concentration of a target nucleic acid in a sample

Method for treating allergic lung disease

Conjugates of synthetic TLR agonists and uses therefor

Method for suppressing multiple drug resistance in cancer cells

Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis

Conjugates of synthetic TLR agonists and uses therefor

Method for the detection of the presence or absence of methylthioadenosine phosphorylase (MTASE) in a cell sample by detection of the presence or absence of MTASE encoding nucleic acid in the cell sample

Use of etodolac for the treatment of prostate cancer

Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

Compounds for inhibition of ceramide-mediated signal transduction

Indole compounds useful for the treatment of cancer

Indole compounds useful for the treatment of cancer

Indole compounds useful for the treatment of cancer

Inhibition of p53-induced stress response

Use of etodolac in the treatment of multiple myeloma

Compositions and methods for modulating TLR4

VICAL INC

Induction of a protective immune response in a mammal by injecting a DNA sequence

Delivery of exogenous DNA sequences in a mammal

Methods of delivering a physiologically active polypeptide to a mammal

Induction of a protective immune response in a mammal by injecting a DNA sequence

Generation of an immune response to a pathogen

Lipid-mediated polynucleotide administration to reduce likelihood of subject&#39;s becoming infected

SCRIPPS RESEARCH INST

2-halo-2&#39;-deoxyadenosines in the treatment of rheumatoid arthritis

Adenosine derivatives with therapeutic activity

2-halo-2&#39;-deoxyadenosines in the treatment of monocyte-mediated inflammatory disease conditions

Adminstration of 2&#39;-halo-2&#39;-deoxy adenosine to treat inflammatory bowel disease

SCRIPPS CLINIC RES

Method for the preparation of anti-receptor antibodies

Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen

Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides

Anti-idiotype antibodies induced by synthetic polypeptides

WISCONSIN ALUMNI RES FOUND

Generation of antibodies through lipid mediated DNA delivery

Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response

CARSON DENNIS A

Toll-like receptor modulators and treatment of diseases

Use of etodolac for the treatment of chronic lymphocytic leukemia

NAXCOR

Use of photodynamic compositions for cytotoxic effects

Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected

2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis

2-halo-2'-deoxyadenosines in the treatment of monocyte-mediated inflammatory disease conditions

Adminstration of 2'-halo-2'-deoxy adenosine to treat inflammatory bowel disease